Sign up
Pharma Capital
Market: ASX
52-week High/Low: A$1.15 / A$0.19
Sector: Pharma & Biotech
Market Cap: A$48.71M

The Hydroponics Company Ltd (ASX:THC) operates under a pharmaceutical model and is currently delivering high quality medicinal cannabis products to Australian patients through the existing access schemes.

Hydroponics Company Ltd

Interactive graph

col 3
col 4
col 5
col 6

Big picture - Why invest in Hydroponics Company Ltd

Hydroponics Company Ltd Snapshot

THC is at the forefront of developing a leading, diversified worldwide cannabis business, focusing on two core business units: Development and delivery of medicinal cannabis, and manufacturing and distribution of hydroponics equipment, materials and nutrients.


(click here for more information on this project)


Last updated 16th July 2018







Suite 305, 35 Lime Street, Sydney, NSW, 2000, Australia

+61 2 9251 7177

[email protected]

View full THC profile View Profile
View All

Executive video interviews


© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.